Vereckei András
Department of Medicine and Hematology, Semmelweis University, Szentkirályi u. 46, 1088 Budapest, Hungary.
J Cardiovasc Dev Dis. 2024 Jul 3;11(7):208. doi: 10.3390/jcdd11070208.
Although cardiac resynchronization therapy (CRT) is an evidence-based effective therapy of symptomatic heart failure with reduced ejection fraction (HFrEF), refractory to optimal medical treatment and associated with intraventricular conduction disturbance, the non-response rate to CRT is still around 30% [...].
尽管心脏再同步治疗(CRT)是一种基于证据的、针对射血分数降低的症状性心力衰竭(HFrEF)的有效治疗方法,适用于对最佳药物治疗无效且伴有室内传导障碍的患者,但CRT的无反应率仍约为30%[...]。